About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange.

The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it added.

The drug, which had branded sales of approximately 1.8 billion dollars in the US market during 2005, is a lipid lowering agent.

Source:PTI News

Recommended Readings

Hyponatremia

Hyponatremia is an electrolyte imbalance causing low blood sodium levels. It is a dangerous condition that causes fluid retention in the brain leading to coma or even death. The causes, symptoms and treatment of hyponatremia are described below.

Hypochloremia

Hypochloremia, an electrolyte imbalance, results in low chloride blood levels. It causes fluid loss and dehydration and mostly occurs with other conditions.

Latest Drug News

Appetite Suppressants and Food Surplus: An Unexpected Link

Appetite Suppressants and Food Surplus: An Unexpected Link

New insights reveal how anti-obesity drugs may contribute to food waste by reducing appetite, leading to uneaten food and increased disposal.

Parkinson's Drug Alters Gut Microbiome Negatively, Linked to Iron Deficiency

Parkinson's Drug Alters Gut Microbiome Negatively, Linked to Iron Deficiency

Parkinson's drug linked to harmful gut microbiome changes, potentially caused by iron deficiency, may worsen gut health and impact treatment outcomes.

How Blood Pressure Drugs May Cause Kidney Damage

How Blood Pressure Drugs May Cause Kidney Damage

New research reveals how certain blood pressure medications may lead to kidney damage by affecting filtration processes, highlighting the need for careful monitoring.

Off-Label Use of Low-Dose Oral Minoxidil for Hair Loss: An Expert Consensus

Off-Label Use of Low-Dose Oral Minoxidil for Hair Loss: An Expert Consensus

Low-dose oral minoxidil is emerging as a treatment for hair loss, with a need for expert guidelines on its safety and efficacy.

Taking NSAIDs With Blood Thinners Doubles Risk of Internal Bleeding, Study Finds

Taking NSAIDs With Blood Thinners Doubles Risk of Internal Bleeding, Study Finds

A new study reveals that combining NSAIDs with blood thinners significantly increases the risk of internal bleeding, urging patients to consult their doctor.

Advertisement